AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
  3. Financials
  4. Cash from investing

TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.【JP:E25678】

Market cap
P/E ratio
SummaryFinancialsDividendsHistoryWorkforce
Period EndCash from investing (Million JPY)YoY (%)
Mar 31, 2023-27,130+284.11%
Mar 31, 2022-7,063+260.73%
Mar 31, 2021-1,958-98.17%
Mar 31, 2020-107,081-262.14%
Mar 31, 201966,044-431.75%
Mar 31, 2018-19,908+1362.75%
Mar 31, 2017-1,361-88.33%
Mar 31, 2016-11,662-35.79%
Mar 31, 2015-18,162-17.44%
Mar 31, 2014-21,998+135.05%
Mar 31, 2013-9,359

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)